297 related articles for article (PubMed ID: 31296232)
41. The FLUKA Monte Carlo code coupled with the local effect model for biological calculations in carbon ion therapy.
Mairani A; Brons S; Cerutti F; Fassò A; Ferrari A; Krämer M; Parodi K; Scholz M; Sommerer F
Phys Med Biol; 2010 Aug; 55(15):4273-89. PubMed ID: 20647603
[TBL] [Abstract][Full Text] [Related]
42. Secondary radiation measurements for particle therapy applications: prompt photons produced by
Mattei I; Bini F; Collamati F; De Lucia E; Frallicciardi PM; Iarocci E; Mancini-Terracciano C; Marafini M; Muraro S; Paramatti R; Patera V; Piersanti L; Pinci D; Rucinski A; Russomando A; Sarti A; Sciubba A; Solfaroli Camillocci E; Toppi M; Traini G; Voena C; Battistoni G
Phys Med Biol; 2017 Feb; 62(4):1438-1455. PubMed ID: 28114112
[TBL] [Abstract][Full Text] [Related]
43. Significance and implementation of RBE variations in proton beam therapy.
Paganetti H
Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
[TBL] [Abstract][Full Text] [Related]
44. Comparative study of dose distributions and cell survival fractions for 1H, 4He, 12C and 16O beams using Geant4 and Microdosimetric Kinetic model.
Burigo L; Pshenichnov I; Mishustin I; Bleicher M
Phys Med Biol; 2015 Apr; 60(8):3313-31. PubMed ID: 25825827
[TBL] [Abstract][Full Text] [Related]
45. A Monte Carlo-based treatment-planning tool for ion beam therapy.
Böhlen TT; Bauer J; Dosanjh M; Ferrari A; Haberer T; Parodi K; Patera V; Mairani A
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i77-81. PubMed ID: 23824131
[TBL] [Abstract][Full Text] [Related]
46. Technical note: Impact of beamline-specific particle energy spectra on clinical plans in carbon ion beam therapy.
Resch AF; Schafasand M; Lackner N; Niessen T; Beck S; Elia A; Boersma D; Grevillot L; Fossati P; Glimelius L; Stock M; Georg D; Carlino A
Med Phys; 2022 Jun; 49(6):4092-4098. PubMed ID: 35416302
[TBL] [Abstract][Full Text] [Related]
47. The potential of mixed carbon-helium beams for online treatment verification: a simulation and treatment planning study.
Hardt JJ; Pryanichnikov AA; Homolka N; DeJongh EA; DeJongh DF; Cristoforetti R; Jäkel O; Seco J; Wahl N
Phys Med Biol; 2024 Jun; 69(12):. PubMed ID: 38697212
[No Abstract] [Full Text] [Related]
48. Dosimetric accuracy and radiobiological implications of ion computed tomography for proton therapy treatment planning.
Meyer S; Kamp F; Tessonnier T; Mairani A; Belka C; Carlson DJ; Gianoli C; Parodi K
Phys Med Biol; 2019 Jun; 64(12):125008. PubMed ID: 30870831
[TBL] [Abstract][Full Text] [Related]
49. In Vivo Validation of the BIANCA Biophysical Model: Benchmarking against Rat Spinal Cord RBE Data.
Carante MP; Aricò G; Ferrari A; Karger CP; Kozlowska W; Mairani A; Sala P; Ballarini F
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492909
[TBL] [Abstract][Full Text] [Related]
50. A pencil beam algorithm for helium ion beam therapy.
Fuchs H; Strobele J; Schreiner T; Hirtl A; Georg D
Med Phys; 2012 Nov; 39(11):6726-37. PubMed ID: 23127066
[TBL] [Abstract][Full Text] [Related]
51. Biological dose optimization incorporating intra-tumoural cellular radiosensitivity heterogeneity in ion-beam therapy treatment planning.
Inaniwa T; Kanematsu N; Koto M
Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38636504
[No Abstract] [Full Text] [Related]
52. Integration and evaluation of automated Monte Carlo simulations in the clinical practice of scanned proton and carbon ion beam therapy.
Bauer J; Sommerer F; Mairani A; Unholtz D; Farook R; Handrack J; Frey K; Marcelos T; Tessonnier T; Ecker S; Ackermann B; Ellerbrock M; Debus J; Parodi K
Phys Med Biol; 2014 Aug; 59(16):4635-59. PubMed ID: 25079387
[TBL] [Abstract][Full Text] [Related]
53. Helium ions for radiotherapy? Physical and biological verifications of a novel treatment modality.
Krämer M; Scifoni E; Schuy C; Rovituso M; Tinganelli W; Maier A; Kaderka R; Kraft-Weyrather W; Brons S; Tessonnier T; Parodi K; Durante M
Med Phys; 2016 Apr; 43(4):1995. PubMed ID: 27036594
[TBL] [Abstract][Full Text] [Related]
54. First application of the BIANCA biophysical model to carbon-ion patient cases.
Kozłowska WS; Carante MP; Aricò G; Embriaco A; Ferrari A; Magro G; Mairani A; Ramos R; Sala P; Georg D; Ballarini F
Phys Med Biol; 2022 May; 67(11):. PubMed ID: 35576922
[No Abstract] [Full Text] [Related]
55. Commissioning a newly developed treatment planning system, VQA Plan, for fast-raster scanning of carbon-ion beams.
Yagi M; Tsubouchi T; Hamatani N; Takashina M; Maruo H; Fujitaka S; Nihongi H; Ogawa K; Kanai T
PLoS One; 2022; 17(5):e0268087. PubMed ID: 35536852
[TBL] [Abstract][Full Text] [Related]
56. Fast robust dose calculation on GPU for high-precision
Mein S; Choi K; Kopp B; Tessonnier T; Bauer J; Ferrari A; Haberer T; Debus J; Abdollahi A; Mairani A
Sci Rep; 2018 Oct; 8(1):14829. PubMed ID: 30287930
[TBL] [Abstract][Full Text] [Related]
57. Monte Carlo-based parametrization of the lateral dose spread for clinical treatment planning of scanned proton and carbon ion beams.
Parodi K; Mairani A; Sommerer F
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i91-6. PubMed ID: 23824133
[TBL] [Abstract][Full Text] [Related]
58. 'Survival': a simulation toolkit introducing a modular approach for radiobiological evaluations in ion beam therapy.
Manganaro L; Russo G; Bourhaleb F; Fausti F; Giordanengo S; Monaco V; Sacchi R; Vignati A; Cirio R; Attili A
Phys Med Biol; 2018 Apr; 63(8):08NT01. PubMed ID: 29537391
[TBL] [Abstract][Full Text] [Related]
59. Data-driven ion-independent relative biological effectiveness modeling using the beam quality Q.
Tian L; Lühr A
Phys Med Biol; 2023 May; 68(10):. PubMed ID: 37011630
[TBL] [Abstract][Full Text] [Related]
60. Modeling in vivo relative biological effectiveness in particle therapy for clinically relevant endpoints.
Lühr A; von Neubeck C; Helmbrecht S; Baumann M; Enghardt W; Krause M
Acta Oncol; 2017 Nov; 56(11):1392-1398. PubMed ID: 28849720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
